The prospectus describes RBD4059, one of Ribo Life's core candidate products, as the world's first and most advanced siRNA ...

Fusobacteria, which are part of the oral microbiome, are suspected of playing a role in cancer progression. Scientists at the ...

In this interview, industry expert Dr. Lohit Khera discusses the evolving role of microRNA in research, diagnostics, and ...

Researchers at Karolinska Institutet and Uppsala University have developed a powerful new technique to better understand how ...

Fusobacteria, part of the oral microbiome, are suspected of playing a role in cancer progression. Scientists are working on ...

Fusobacteria, which are part of the oral microbiome, are suspected of playing a role in cancer progression. Scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) are working on ...

Inc. Creyon Bio is a nucleic acid drug development company whose goal is to make oligonucleotide (oligo) therapies safer and more effective for patients with rare and common diseases. The company is ...

The influenza virus manipulates the body’s gene regulation system to accelerate its own spread, according to researchers at ...